S3 Ep22: Alex Moulson on How Companies Choose Which Biosimilars to Produce - a podcast by Not So Different: a Podcast from The Center for Biosimilars
from 2020-09-13T11:00
::
::
To check out more of our coverage of Polpharma Biologics, click here.
To learn more about Polpharma's natalizumab clinical trial, click here.
To learn about Polpharma Biologics recent integration efforts, click here.
To learn more about Polpharma Biologics, click here.
To learn more about Polpharma's natalizumab clinical trial, click here.
To learn about Polpharma Biologics recent integration efforts, click here.
To learn more about Polpharma Biologics, click here.
Further episodes of Not So Different: a Podcast from The Center for Biosimilars
Further podcasts by Not So Different: a Podcast from The Center for Biosimilars
Website of Not So Different: a Podcast from The Center for Biosimilars